Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: A Registry: Siltartoxatug Injection for Tetanus Prophylaxis Following Injury

View source ↗

Summary

A registry entry describing a clinical trial evaluating Siltartoxatug Injection for tetanus prophylaxis after injury, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Siltartoxatug Injection

Snippet

Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. | Conditions: Tetanus | Status: RECRUITING